Skip to main content
Filing year 2024

RIVKIN CENTER FOR OVARIAN CANCER

Seattle, Washington·EIN 91-2054035·NTEE H30 · Medical Research·3
Total revenue
$1.7M
Total assets
$2M
Total expenses
$0
Reported officers
14
Mission

WE ENVISION A WORLD WHERE WOMEN LIVE LONGER AND HEALTHIER LIVES BECAUSE OVARIAN CANCER CAN BE PREVENTED, CAUGHT EARLY, OR CURED.

Executive compensation, broken down

Form 990 · Schedule J · 2 reported individuals · Filing year 2024

Base salaryBonusOther compensationBenefits
Base salaryBonusOther compensationBenefitsExecutive compensation
Development Director (until 4/2024)
$35k

Plus 12 unpaid individuals.

Browse compensation in Medical Research

Up 1%
from 2023

From $183k in 2023 to $186k in 2024.

$183k
2023
$186k
2024
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.